Peptides / CJC-1295
CJC-1295
(GRF 1-29, CJC-1295 with DAC)T3peptidepreclinical
Biomarker Effects
Growth hormone
↑ large
Stimulates pituitary GH release
IGF-1
↑ large
GH/IGF-1 axis activation
IGFBP-3
↑ moderate
GH-mediated binding proteins
Dosing & Pharmacokinetics
Typical Dose0.1 mg
Frequencydaily
Routeclinician-directed
Half-Life8 hr
Safety & Evidence
CJC-1295 is a Growth Hormone Releasing Hormone (GHRH) analog with a Drug Affinity Complex (DAC) that extends half-life. Promotes GH and IGF-1 secretion. Not FDA-approved.
Sources
Track CJC-1295 precisely in the Vivy app.
Your precision instrument awaits.
Download Vivy